您的位置: 首页 > 农业专利 > 详情页

GENETICALLY ENGINEERED COXSACKIEVIRUS, AND PHARMACEUTICAL COMPOSITION
专利权人:
THE UNIVERSITY OF TOKYO;SHIN NIHON SEIYAKU CO., LTD.
发明人:
Yang JIA,Shohei MIYAMOTO,Kenichiro HARA,Atsuhumi IWANAGA,Kenzaburo TANI
申请号:
US16606685
公开号:
US20200231941A1
申请日:
2018.04.18
申请国别(地区):
US
年份:
2020
代理人:
摘要:
A gene-modified coxsackievirus that is to be used in oncolytic virotherapy and is improved in safety and/or aggressiveness is provided. A gene-modified coxsackievirus that contains a mutated genome with a coxsackievirus B3 wild-type (CVB3-WT) genome inserted with at least one polynucleotide constituted of a target sequence for at least one of either of miR-34a and miR-34c and is suppressed in proliferation in normal cells is provided.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充